ROSEN, NATIONAL TRIAL COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action – EGRX Feb 4, 2024 01:08PM
ROSEN, A LEADING LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action – EGRX Feb 1, 2024 08:13PM
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EGRX Jan 22, 2024 05:59PM
ROSEN, A RANKED AND LEADING FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EGRX Jan 16, 2024 05:46PM
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EGRX Jan 8, 2024 06:31PM


Jun 14, 2016 11:52AM SHAREHOLDER NOTICE: Goldberg Law PC Announces An Investigation of Claims Against Eagle Pharmaceuticals Inc. And Advises Investors With Losses To Contact The Firm
Jun 8, 2016 03:39PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Eagle Pharmaceuticals Inc. and Advises Investors With Losses to Contact the Firm
Jan 11, 2016 06:52AM Albany Molecular Research (AMRI), Eagle Pharma (EGRX) Enter Parenteral Drug Products R&D Collaboration
Jan 11, 2016 06:50AM Eagle Pharmaceuticals and AMRI Announce Agreement to Jointly Develop, Manufacture and Commercialize Parenteral Drug Products